at Zacks.com (Jan 12, 2015)
Teva (TEVA -1.4%) makes a few management changes to its executive leadership team, appointing SVP Allan Oberman to President and CEO of Teva Americas Generics, replacing current chief executive William Marth who will step down and retire at the end of 2013. The company also promotes Jill DeSimone to the newly created position of SVP and General Manager of Teva Global Women’s Health franchise. Ms. DeSimone is a seasoned veteran in specialty medicine franchising, and will manage all aspects of building the business.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 9, 2015)
at CNBC.com (Jan 5, 2015)
at Zacks.com (Dec 31, 2014)
at Nasdaq.com (Dec 31, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs